

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | dopamine transport (GO:0015872) | 9.53655246 |
| 2 | sensory perception of chemical stimulus (GO:0007606) | 9.17374228 |
| 3 | dopamine biosynthetic process (GO:0042416) | 8.81256948 |
| 4 | protein insertion into membrane (GO:0051205) | 8.07611452 |
| 5 | catecholamine transport (GO:0051937) | 7.22871540 |
| 6 | protein polyglutamylation (GO:0018095) | 6.88982305 |
| 7 | phenol-containing compound catabolic process (GO:0019336) | 6.67008752 |
| 8 | prepulse inhibition (GO:0060134) | 6.58228505 |
| 9 | protein localization to cilium (GO:0061512) | 6.28670610 |
| 10 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 6.07827183 |
| 11 | synaptic vesicle maturation (GO:0016188) | 6.02991589 |
| 12 | neurotransmitter biosynthetic process (GO:0042136) | 5.73659859 |
| 13 | mating behavior (GO:0007617) | 5.56921297 |
| 14 | synaptic vesicle exocytosis (GO:0016079) | 5.51926897 |
| 15 | catechol-containing compound biosynthetic process (GO:0009713) | 5.39842202 |
| 16 | catecholamine biosynthetic process (GO:0042423) | 5.39842202 |
| 17 | regulation of catecholamine metabolic process (GO:0042069) | 5.27437600 |
| 18 | regulation of dopamine metabolic process (GO:0042053) | 5.27437600 |
| 19 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.25387636 |
| 20 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.22487245 |
| 21 | neuronal action potential (GO:0019228) | 5.02666628 |
| 22 | regulation of cilium movement (GO:0003352) | 4.99406280 |
| 23 | response to insecticide (GO:0017085) | 4.98926690 |
| 24 | cellular response to nicotine (GO:0071316) | 4.97567958 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.97489658 |
| 26 | neurotransmitter transport (GO:0006836) | 4.84892820 |
| 27 | neurotransmitter secretion (GO:0007269) | 4.80321521 |
| 28 | regulation of cell communication by electrical coupling (GO:0010649) | 4.79278469 |
| 29 | response to manganese ion (GO:0010042) | 4.71719692 |
| 30 | dopamine receptor signaling pathway (GO:0007212) | 4.69667617 |
| 31 | dopamine metabolic process (GO:0042417) | 4.57345840 |
| 32 | monoamine transport (GO:0015844) | 4.53559837 |
| 33 | regulation of neurotransmitter levels (GO:0001505) | 4.46547821 |
| 34 | neuronal action potential propagation (GO:0019227) | 4.44501642 |
| 35 | response to cocaine (GO:0042220) | 4.39735308 |
| 36 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.39559047 |
| 37 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.33436680 |
| 38 | negative regulation of complement activation (GO:0045916) | 4.32095120 |
| 39 | regulation of female gonad development (GO:2000194) | 4.24492934 |
| 40 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.23285329 |
| 41 | synaptic transmission, dopaminergic (GO:0001963) | 4.23164050 |
| 42 | sequestering of actin monomers (GO:0042989) | 4.18872431 |
| 43 | detection of calcium ion (GO:0005513) | 4.17397834 |
| 44 | membrane depolarization during action potential (GO:0086010) | 4.16931249 |
| 45 | neurotransmitter metabolic process (GO:0042133) | 4.12170439 |
| 46 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.04593329 |
| 47 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.03567085 |
| 48 | response to amphetamine (GO:0001975) | 4.02974055 |
| 49 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.98001994 |
| 50 | activation of protein kinase A activity (GO:0034199) | 3.94244606 |
| 51 | axoneme assembly (GO:0035082) | 3.94107279 |
| 52 | sodium ion export (GO:0071436) | 3.93232159 |
| 53 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.82916423 |
| 54 | neuron-neuron synaptic transmission (GO:0007270) | 3.82662152 |
| 55 | negative regulation of cation channel activity (GO:2001258) | 3.82352461 |
| 56 | behavioral response to cocaine (GO:0048148) | 3.82009959 |
| 57 | behavioral response to pain (GO:0048266) | 3.81657644 |
| 58 | negative regulation of neurotransmitter transport (GO:0051589) | 3.79760774 |
| 59 | exploration behavior (GO:0035640) | 3.78862401 |
| 60 | response to water (GO:0009415) | 3.77307264 |
| 61 | regulation of chromatin binding (GO:0035561) | 3.74208370 |
| 62 | cilium morphogenesis (GO:0060271) | 3.73942933 |
| 63 | regulation of synapse structural plasticity (GO:0051823) | 3.73168178 |
| 64 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.72770960 |
| 65 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.71272934 |
| 66 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.70985599 |
| 67 | protein localization to synapse (GO:0035418) | 3.65911312 |
| 68 | neuron cell-cell adhesion (GO:0007158) | 3.65814168 |
| 69 | locomotory exploration behavior (GO:0035641) | 3.65619423 |
| 70 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.64478547 |
| 71 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.64056928 |
| 72 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.62200690 |
| 73 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.60259230 |
| 74 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.56704313 |
| 75 | peristalsis (GO:0030432) | 3.55769145 |
| 76 | negative regulation of protein activation cascade (GO:2000258) | 3.55473848 |
| 77 | synaptic vesicle endocytosis (GO:0048488) | 3.51280963 |
| 78 | negative regulation of microtubule polymerization (GO:0031115) | 3.49447079 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 3.49092849 |
| 80 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.48714956 |
| 81 | glutamate secretion (GO:0014047) | 3.48375129 |
| 82 | positive regulation of synapse maturation (GO:0090129) | 3.48280280 |
| 83 | microtubule severing (GO:0051013) | 3.46716872 |
| 84 | regulation of vesicle fusion (GO:0031338) | 3.45476402 |
| 85 | urinary tract smooth muscle contraction (GO:0014848) | 3.43520716 |
| 86 | plasma membrane repair (GO:0001778) | 3.43339639 |
| 87 | potassium ion export (GO:0071435) | 3.42945077 |
| 88 | cellular response to glucagon stimulus (GO:0071377) | 3.42887509 |
| 89 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.41636555 |
| 90 | response to nicotine (GO:0035094) | 3.38352644 |
| 91 | synaptic transmission, glutamatergic (GO:0035249) | 3.38122890 |
| 92 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.36974287 |
| 93 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.30961274 |
| 94 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.30609312 |
| 95 | regulation of neurotransmitter secretion (GO:0046928) | 3.29621180 |
| 96 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.28089787 |
| 97 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.26929714 |
| 98 | negative regulation of sodium ion transport (GO:0010766) | 3.26591418 |
| 99 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.26086849 |
| 100 | cellular potassium ion transport (GO:0071804) | 3.25029177 |
| 101 | potassium ion transmembrane transport (GO:0071805) | 3.25029177 |
| 102 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.22592356 |
| 103 | regulation of microtubule-based movement (GO:0060632) | 3.22256049 |
| 104 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.22112104 |
| 105 | positive regulation of neurotransmitter transport (GO:0051590) | 3.21416249 |
| 106 | response to corticosterone (GO:0051412) | 3.20162228 |
| 107 | regulation of protein kinase A signaling (GO:0010738) | 3.19282727 |
| 108 | neurotransmitter uptake (GO:0001504) | 3.19017159 |
| 109 | L-amino acid import (GO:0043092) | 3.18114549 |
| 110 | phenol-containing compound biosynthetic process (GO:0046189) | 3.16655120 |
| 111 | microtubule bundle formation (GO:0001578) | 3.16500580 |
| 112 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.16253991 |
| 113 | cell migration in hindbrain (GO:0021535) | 3.15454613 |
| 114 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.12464035 |
| 115 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.12464035 |
| 116 | alkaloid metabolic process (GO:0009820) | 3.11984481 |
| 117 | auditory behavior (GO:0031223) | 3.11044522 |
| 118 | establishment of synaptic vesicle localization (GO:0097480) | 3.10778917 |
| 119 | synaptic vesicle transport (GO:0048489) | 3.10778917 |
| 120 | intraciliary transport (GO:0042073) | 3.10773231 |
| 121 | regulation of sodium ion transmembrane transport (GO:1902305) | 3.09223725 |
| 122 | intraspecies interaction between organisms (GO:0051703) | 3.07791307 |
| 123 | social behavior (GO:0035176) | 3.07791307 |
| 124 | regulation of synaptic plasticity (GO:0048167) | 3.07610718 |
| 125 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.07415807 |
| 126 | cerebellar granule cell differentiation (GO:0021707) | 3.07040878 |
| 127 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.05782343 |
| 128 | glutamate receptor signaling pathway (GO:0007215) | 3.05650159 |
| 129 | potassium ion import (GO:0010107) | 3.03666445 |
| 130 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.03117913 |
| 131 | sensory perception of taste (GO:0050909) | 3.02354258 |
| 132 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.00330495 |
| 133 | negative regulation of humoral immune response (GO:0002921) | 3.00262420 |
| 134 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.00123114 |
| 135 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.99546890 |
| 136 | response to pain (GO:0048265) | 2.99492240 |
| 137 | potassium ion transport (GO:0006813) | 2.99268007 |
| 138 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.98954957 |
| 139 | vocalization behavior (GO:0071625) | 2.98695468 |
| 140 | cellular potassium ion homeostasis (GO:0030007) | 2.98359075 |
| 141 | postsynaptic membrane organization (GO:0001941) | 2.98031056 |
| 142 | membrane repolarization (GO:0086009) | 2.97791671 |
| 143 | adenosine metabolic process (GO:0046085) | 2.97566061 |
| 144 | response to ammonium ion (GO:0060359) | 2.97307553 |
| 145 | membrane depolarization (GO:0051899) | 2.96584831 |
| 146 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.96002796 |
| 147 | melanosome transport (GO:0032402) | 2.94900498 |
| 148 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.94870681 |
| 149 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.94870681 |
| 150 | vesicle transport along microtubule (GO:0047496) | 2.94824499 |
| 151 | action potential (GO:0001508) | 2.90698354 |
| 152 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.90564781 |
| 153 | regulation of postsynaptic membrane potential (GO:0060078) | 2.90255082 |
| 154 | skeletal muscle fiber development (GO:0048741) | 2.89859434 |
| 155 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.89589814 |
| 156 | response to mineralocorticoid (GO:0051385) | 2.89324311 |
| 157 | synaptic transmission (GO:0007268) | 2.89111517 |
| 158 | positive regulation of vesicle fusion (GO:0031340) | 2.88953490 |
| 159 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.87588809 |
| 160 | catecholamine metabolic process (GO:0006584) | 2.87451556 |
| 161 | catechol-containing compound metabolic process (GO:0009712) | 2.87451556 |
| 162 | neurofilament cytoskeleton organization (GO:0060052) | 2.86198091 |
| 163 | cellular response to prostaglandin stimulus (GO:0071379) | 2.86195292 |
| 164 | positive regulation of muscle hypertrophy (GO:0014742) | 2.85189162 |
| 165 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.85189162 |
| 166 | cell communication involved in cardiac conduction (GO:0086065) | 2.84740015 |
| 167 | glycogen catabolic process (GO:0005980) | 2.84330681 |
| 168 | response to caffeine (GO:0031000) | 2.83500612 |
| 169 | melanosome localization (GO:0032400) | 2.82310256 |
| 170 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.80893104 |
| 171 | regulation of membrane repolarization (GO:0060306) | 2.78885269 |
| 172 | regulation of dopamine secretion (GO:0014059) | 2.78383411 |
| 173 | establishment of melanosome localization (GO:0032401) | 2.77777341 |
| 174 | pigment granule transport (GO:0051904) | 2.77362791 |
| 175 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.76066572 |
| 176 | brain morphogenesis (GO:0048854) | 2.71428115 |
| 177 | peripheral nervous system neuron development (GO:0048935) | 2.69576783 |
| 178 | acrosome reaction (GO:0007340) | 2.68654180 |
| 179 | regulation of cation channel activity (GO:2001257) | 2.68412396 |
| 180 | neuromuscular synaptic transmission (GO:0007274) | 2.68052746 |
| 181 | calcium ion-dependent exocytosis (GO:0017156) | 2.67496995 |
| 182 | pigment granule localization (GO:0051875) | 2.67489356 |
| 183 | striatum development (GO:0021756) | 2.65379103 |
| 184 | sensory perception of smell (GO:0007608) | 14.8068272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.53865383 |
| 2 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.66518230 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.19630764 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.95775420 |
| 5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.90133161 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.66576812 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.56724693 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.52874610 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.32519253 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.23333690 |
| 11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.22489574 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.12576121 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.12576121 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07680613 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.05944358 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.01545999 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.93037711 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.90333248 |
| 19 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.87672111 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.86395163 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.85557570 |
| 22 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.84907212 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.84472356 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.81988714 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.80642963 |
| 26 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.77162319 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.76451175 |
| 28 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.75038046 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.74684086 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.71024609 |
| 31 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.66713532 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.66088497 |
| 33 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.65963469 |
| 34 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.65327460 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.60323786 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.60198411 |
| 37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.58924039 |
| 38 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.53508256 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53032786 |
| 40 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.52183385 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.51383543 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50718124 |
| 43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50044348 |
| 44 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.49183307 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.48546628 |
| 46 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.45569956 |
| 47 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.44417577 |
| 48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.39148941 |
| 49 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35972961 |
| 50 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.34064736 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.32539253 |
| 52 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.32347336 |
| 53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.32245315 |
| 54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.31574645 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30654373 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27394535 |
| 57 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25061685 |
| 58 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.24642013 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23041977 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21965612 |
| 61 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21265381 |
| 62 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.21241397 |
| 63 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.20935429 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20860471 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20727237 |
| 66 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17968619 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16223471 |
| 68 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16183363 |
| 69 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.15374580 |
| 70 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.14381281 |
| 71 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13070629 |
| 72 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12837616 |
| 73 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.12719554 |
| 74 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12719554 |
| 75 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.10565949 |
| 76 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07502750 |
| 77 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.07308928 |
| 78 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07247623 |
| 79 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.06555183 |
| 80 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.05220399 |
| 81 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.04621520 |
| 82 | * AR_19668381_ChIP-Seq_PC3_Human | 1.04601151 |
| 83 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.04272809 |
| 84 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03337147 |
| 85 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.03099487 |
| 86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02640564 |
| 87 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01659355 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01294446 |
| 89 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00704501 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00291577 |
| 91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99509943 |
| 92 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99330974 |
| 93 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98967223 |
| 94 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98029686 |
| 95 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98013638 |
| 96 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.96467674 |
| 97 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96397843 |
| 98 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96302918 |
| 99 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.95722750 |
| 100 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.95679435 |
| 101 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95373461 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95102849 |
| 103 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.95093427 |
| 104 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94511885 |
| 105 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.94409493 |
| 106 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94249425 |
| 107 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93498482 |
| 108 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.92770536 |
| 109 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92388487 |
| 110 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91555156 |
| 111 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.91193010 |
| 112 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91036973 |
| 113 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90715446 |
| 114 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.90657682 |
| 115 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89121661 |
| 116 | JUN_21703547_ChIP-Seq_K562_Human | 0.88650278 |
| 117 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87246653 |
| 118 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.86904769 |
| 119 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85950248 |
| 120 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.85914884 |
| 121 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85025286 |
| 122 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.84664803 |
| 123 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.83951190 |
| 124 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83617183 |
| 125 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.83519177 |
| 126 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.83039203 |
| 127 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.83005221 |
| 128 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.82787485 |
| 129 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.82787485 |
| 130 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.82638969 |
| 131 | NCOR_22424771_ChIP-Seq_293T_Human | 0.82434226 |
| 132 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.82225470 |
| 133 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81097236 |
| 134 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.80913227 |
| 135 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77810520 |
| 136 | KDM2B_26808549_Chip-Seq_REH_Human | 0.77622425 |
| 137 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.77169063 |
| 138 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.76746509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001968_abnormal_touch/_nociception | 4.17454495 |
| 2 | MP0002735_abnormal_chemical_nociception | 4.09106486 |
| 3 | MP0002736_abnormal_nociception_after | 4.05715488 |
| 4 | MP0002734_abnormal_mechanical_nocicepti | 3.46761444 |
| 5 | MP0004270_analgesia | 3.05119652 |
| 6 | MP0008789_abnormal_olfactory_epithelium | 3.05083771 |
| 7 | MP0005499_abnormal_olfactory_system | 2.69889222 |
| 8 | MP0005394_taste/olfaction_phenotype | 2.69889222 |
| 9 | MP0001986_abnormal_taste_sensitivity | 2.55137352 |
| 10 | MP0002184_abnormal_innervation | 2.50923462 |
| 11 | MP0001970_abnormal_pain_threshold | 2.48557661 |
| 12 | MP0002733_abnormal_thermal_nociception | 2.44870414 |
| 13 | MP0004145_abnormal_muscle_electrophysio | 2.40802272 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.19895858 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.18595095 |
| 16 | MP0003880_abnormal_central_pattern | 2.15847662 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.12058281 |
| 18 | MP0002272_abnormal_nervous_system | 2.06876885 |
| 19 | MP0004858_abnormal_nervous_system | 2.01163332 |
| 20 | MP0001984_abnormal_olfaction | 11.5266611 |
| 21 | MP0002822_catalepsy | 1.88624943 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 1.85057632 |
| 23 | MP0008872_abnormal_physiological_respon | 1.80537884 |
| 24 | MP0004859_abnormal_synaptic_plasticity | 1.67908579 |
| 25 | MP0003635_abnormal_synaptic_transmissio | 1.65885524 |
| 26 | MP0001188_hyperpigmentation | 1.63055767 |
| 27 | MP0000372_irregular_coat_pigmentation | 1.58950372 |
| 28 | MP0003329_amyloid_beta_deposits | 1.56773016 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.49214626 |
| 30 | MP0001177_atelectasis | 1.48354094 |
| 31 | MP0002160_abnormal_reproductive_system | 1.36708352 |
| 32 | MP0002653_abnormal_ependyma_morphology | 1.34557923 |
| 33 | MP0002837_dystrophic_cardiac_calcinosis | 1.31671071 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.31420553 |
| 35 | MP0000749_muscle_degeneration | 1.29500616 |
| 36 | MP0002064_seizures | 1.23329441 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.20710777 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.19415458 |
| 39 | MP0002063_abnormal_learning/memory/cond | 1.18350787 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.18331600 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.17842971 |
| 42 | MP0002332_abnormal_exercise_endurance | 1.15833862 |
| 43 | MP0000751_myopathy | 1.15005343 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.14008778 |
| 45 | MP0004043_abnormal_pH_regulation | 1.12948975 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.11689718 |
| 47 | MP0002752_abnormal_somatic_nervous | 1.11519662 |
| 48 | MP0003690_abnormal_glial_cell | 1.10091348 |
| 49 | MP0003646_muscle_fatigue | 1.09146641 |
| 50 | MP0002638_abnormal_pupillary_reflex | 1.07469886 |
| 51 | MP0002928_abnormal_bile_duct | 1.07404021 |
| 52 | MP0000747_muscle_weakness | 1.06730279 |
| 53 | MP0009046_muscle_twitch | 1.05733021 |
| 54 | MP0005646_abnormal_pituitary_gland | 1.05619469 |
| 55 | MP0004036_abnormal_muscle_relaxation | 1.04876708 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.04492031 |
| 57 | MP0000631_abnormal_neuroendocrine_gland | 1.02998532 |
| 58 | MP0009745_abnormal_behavioral_response | 1.02934328 |
| 59 | MP0004885_abnormal_endolymph | 1.01190132 |
| 60 | MP0005084_abnormal_gallbladder_morpholo | 1.01016293 |
| 61 | MP0005423_abnormal_somatic_nervous | 0.99884933 |
| 62 | MP0001486_abnormal_startle_reflex | 0.99556391 |
| 63 | MP0001270_distended_abdomen | 0.98921056 |
| 64 | MP0004233_abnormal_muscle_weight | 0.98822605 |
| 65 | MP0002572_abnormal_emotion/affect_behav | 0.97592386 |
| 66 | MP0005535_abnormal_body_temperature | 0.97479086 |
| 67 | MP0009780_abnormal_chondrocyte_physiolo | 0.96923590 |
| 68 | MP0001542_abnormal_bone_strength | 0.96503449 |
| 69 | MP0003787_abnormal_imprinting | 0.94360723 |
| 70 | MP0003632_abnormal_nervous_system | 0.93925793 |
| 71 | MP0000778_abnormal_nervous_system | 0.93022850 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 0.91149014 |
| 73 | MP0008874_decreased_physiological_sensi | 0.87909946 |
| 74 | MP0005367_renal/urinary_system_phenotyp | 0.87659419 |
| 75 | MP0000516_abnormal_urinary_system | 0.87659419 |
| 76 | MP0001485_abnormal_pinna_reflex | 0.87172055 |
| 77 | MP0004084_abnormal_cardiac_muscle | 0.87050416 |
| 78 | MP0003633_abnormal_nervous_system | 0.86073442 |
| 79 | MP0005409_darkened_coat_color | 0.85946130 |
| 80 | MP0005377_hearing/vestibular/ear_phenot | 0.85666647 |
| 81 | MP0003878_abnormal_ear_physiology | 0.85666647 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.83179360 |
| 83 | MP0005410_abnormal_fertilization | 0.81979470 |
| 84 | MP0000920_abnormal_myelination | 0.80864552 |
| 85 | MP0000538_abnormal_urinary_bladder | 0.80040618 |
| 86 | MP0000955_abnormal_spinal_cord | 0.79829966 |
| 87 | MP0002751_abnormal_autonomic_nervous | 0.79134849 |
| 88 | MP0004130_abnormal_muscle_cell | 0.78954903 |
| 89 | MP0000750_abnormal_muscle_regeneration | 0.76788280 |
| 90 | MP0003634_abnormal_glial_cell | 0.74484115 |
| 91 | MP0002229_neurodegeneration | 0.74201261 |
| 92 | MP0004142_abnormal_muscle_tone | 0.70736606 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.70625887 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.70210190 |
| 95 | MP0002066_abnormal_motor_capabilities/c | 0.69103256 |
| 96 | MP0002106_abnormal_muscle_physiology | 0.68152873 |
| 97 | MP0003879_abnormal_hair_cell | 0.67994081 |
| 98 | MP0000759_abnormal_skeletal_muscle | 0.67906391 |
| 99 | MP0001943_abnormal_respiration | 0.65746202 |
| 100 | MP0001529_abnormal_vocalization | 0.65639330 |
| 101 | MP0000013_abnormal_adipose_tissue | 0.64406475 |
| 102 | MP0001905_abnormal_dopamine_level | 0.64130393 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.64078673 |
| 104 | MP0003137_abnormal_impulse_conducting | 0.63944341 |
| 105 | MP0003693_abnormal_embryo_hatching | 0.62327738 |
| 106 | MP0005620_abnormal_muscle_contractility | 0.61948204 |
| 107 | MP0004087_abnormal_muscle_fiber | 0.60958882 |
| 108 | MP0002972_abnormal_cardiac_muscle | 0.60562899 |
| 109 | MP0004484_altered_response_of | 0.60498976 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.60101526 |
| 111 | MP0002152_abnormal_brain_morphology | 0.59944248 |
| 112 | MP0005187_abnormal_penis_morphology | 0.59235315 |
| 113 | MP0006035_abnormal_mitochondrial_morpho | 0.58602963 |
| 114 | MP0004924_abnormal_behavior | 0.58503161 |
| 115 | MP0005386_behavior/neurological_phenoty | 0.58503161 |
| 116 | MP0004085_abnormal_heartbeat | 0.58300724 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.58185823 |
| 118 | MP0001440_abnormal_grooming_behavior | 0.57953326 |
| 119 | MP0003631_nervous_system_phenotype | 0.57414034 |
| 120 | MP0004510_myositis | 0.56725885 |
| 121 | MP0003122_maternal_imprinting | 0.56682473 |
| 122 | MP0004147_increased_porphyrin_level | 0.55512541 |
| 123 | MP0010386_abnormal_urinary_bladder | 0.55135282 |
| 124 | MP0000604_amyloidosis | 0.55038112 |
| 125 | MP0002877_abnormal_melanocyte_morpholog | 0.55013530 |
| 126 | MP0001664_abnormal_digestion | 0.54598901 |
| 127 | MP0005369_muscle_phenotype | 0.54132891 |
| 128 | MP0008569_lethality_at_weaning | 0.53848397 |
| 129 | MP0002269_muscular_atrophy | 0.53201226 |
| 130 | MP0005389_reproductive_system_phenotype | 0.52586935 |
| 131 | MP0003075_altered_response_to | 0.51963479 |
| 132 | MP0004215_abnormal_myocardial_fiber | 0.50682038 |
| 133 | MP0004742_abnormal_vestibular_system | 0.50555085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retinal dysplasia (HP:0007973) | 6.39487296 |
| 2 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 6.18826240 |
| 3 | Hypokinesia (HP:0002375) | 5.45214816 |
| 4 | Postural instability (HP:0002172) | 5.18343599 |
| 5 | Limb dystonia (HP:0002451) | 5.12289665 |
| 6 | Myokymia (HP:0002411) | 4.79338403 |
| 7 | Hypothermia (HP:0002045) | 4.72619477 |
| 8 | Atonic seizures (HP:0010819) | 4.67870031 |
| 9 | Akinesia (HP:0002304) | 4.47412202 |
| 10 | Rigidity (HP:0002063) | 4.35730262 |
| 11 | Palpitations (HP:0001962) | 4.34081015 |
| 12 | Diminished movement (HP:0002374) | 4.31003891 |
| 13 | Myotonia (HP:0002486) | 4.30832202 |
| 14 | Bradykinesia (HP:0002067) | 4.19593661 |
| 15 | Bifid tongue (HP:0010297) | 4.17235404 |
| 16 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.12519938 |
| 17 | Abnormality of macular pigmentation (HP:0008002) | 4.05525734 |
| 18 | Abnormality of binocular vision (HP:0011514) | 4.01369766 |
| 19 | Diplopia (HP:0000651) | 4.01369766 |
| 20 | Distal arthrogryposis (HP:0005684) | 3.96535563 |
| 21 | Impaired pain sensation (HP:0007328) | 3.78728443 |
| 22 | Abnormality of pain sensation (HP:0010832) | 3.78728443 |
| 23 | Torticollis (HP:0000473) | 3.71702033 |
| 24 | Febrile seizures (HP:0002373) | 3.65571159 |
| 25 | Dyskinesia (HP:0100660) | 3.58305170 |
| 26 | Delayed gross motor development (HP:0002194) | 3.56135076 |
| 27 | Dysautonomia (HP:0002459) | 3.51986273 |
| 28 | Dysphonia (HP:0001618) | 3.51474230 |
| 29 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.50952568 |
| 30 | Molar tooth sign on MRI (HP:0002419) | 3.40483639 |
| 31 | Abnormality of midbrain morphology (HP:0002418) | 3.40483639 |
| 32 | Absence seizures (HP:0002121) | 3.36489474 |
| 33 | Mask-like facies (HP:0000298) | 3.34244739 |
| 34 | Focal seizures (HP:0007359) | 3.33597249 |
| 35 | Craniofacial dystonia (HP:0012179) | 3.27677293 |
| 36 | Gait imbalance (HP:0002141) | 3.22805071 |
| 37 | Muscle fiber inclusion bodies (HP:0100299) | 3.20680696 |
| 38 | Morphological abnormality of the pyramidal tract (HP:0002062) | 3.15200893 |
| 39 | Abnormal ciliary motility (HP:0012262) | 3.15158686 |
| 40 | Congenital primary aphakia (HP:0007707) | 3.10150880 |
| 41 | Dialeptic seizures (HP:0011146) | 3.09761044 |
| 42 | Focal dystonia (HP:0004373) | 3.06676175 |
| 43 | Sudden death (HP:0001699) | 3.02856023 |
| 44 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.00898649 |
| 45 | Rhinitis (HP:0012384) | 2.99868119 |
| 46 | Nephrogenic diabetes insipidus (HP:0009806) | 2.98418252 |
| 47 | Anosmia (HP:0000458) | 2.96329575 |
| 48 | Pheochromocytoma (HP:0002666) | 2.92186758 |
| 49 | Medial flaring of the eyebrow (HP:0010747) | 2.89733230 |
| 50 | Termporal pattern (HP:0011008) | 2.86723565 |
| 51 | Insidious onset (HP:0003587) | 2.86723565 |
| 52 | Abolished electroretinogram (ERG) (HP:0000550) | 2.83374876 |
| 53 | Rapidly progressive (HP:0003678) | 2.82717759 |
| 54 | Neuroendocrine neoplasm (HP:0100634) | 2.79704695 |
| 55 | Genital tract atresia (HP:0001827) | 2.77687519 |
| 56 | Vaginal atresia (HP:0000148) | 2.77295870 |
| 57 | Syncope (HP:0001279) | 2.76914337 |
| 58 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.75419380 |
| 59 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.75419380 |
| 60 | Exercise-induced myalgia (HP:0003738) | 2.75400925 |
| 61 | Fetal akinesia sequence (HP:0001989) | 2.68933985 |
| 62 | Bradycardia (HP:0001662) | 2.66950734 |
| 63 | Nemaline bodies (HP:0003798) | 2.66573021 |
| 64 | Muscle stiffness (HP:0003552) | 2.62009090 |
| 65 | Foot dorsiflexor weakness (HP:0009027) | 2.55228128 |
| 66 | Status epilepticus (HP:0002133) | 2.54587214 |
| 67 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.51790763 |
| 68 | Progressive macrocephaly (HP:0004481) | 2.51542395 |
| 69 | Acute necrotizing encephalopathy (HP:0006965) | 2.48755247 |
| 70 | Difficulty running (HP:0009046) | 2.48591773 |
| 71 | Poor eye contact (HP:0000817) | 2.48502459 |
| 72 | Hyporeflexia of lower limbs (HP:0002600) | 2.48358034 |
| 73 | Progressive cerebellar ataxia (HP:0002073) | 2.46313666 |
| 74 | Increased circulating renin level (HP:0000848) | 2.46014002 |
| 75 | Muscle fiber splitting (HP:0003555) | 2.45633521 |
| 76 | Slow saccadic eye movements (HP:0000514) | 2.45589218 |
| 77 | Truncal ataxia (HP:0002078) | 2.44042884 |
| 78 | Generalized tonic-clonic seizures (HP:0002069) | 2.43669716 |
| 79 | Abnormal eating behavior (HP:0100738) | 2.39113687 |
| 80 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.38855386 |
| 81 | Abnormality of saccadic eye movements (HP:0000570) | 2.38350232 |
| 82 | Ankle clonus (HP:0011448) | 2.36354484 |
| 83 | Poor coordination (HP:0002370) | 2.36269098 |
| 84 | Acute encephalopathy (HP:0006846) | 2.36009190 |
| 85 | Visual hallucinations (HP:0002367) | 2.35759103 |
| 86 | Action tremor (HP:0002345) | 2.34855046 |
| 87 | Neurofibrillary tangles (HP:0002185) | 2.31965404 |
| 88 | Hemiplegia (HP:0002301) | 2.30454108 |
| 89 | Abnormality of the foot musculature (HP:0001436) | 2.30301867 |
| 90 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.30167435 |
| 91 | Bundle branch block (HP:0011710) | 2.30106995 |
| 92 | Areflexia of lower limbs (HP:0002522) | 2.30101407 |
| 93 | Type 1 muscle fiber predominance (HP:0003803) | 2.29039297 |
| 94 | Muscular hypotonia of the trunk (HP:0008936) | 2.29024082 |
| 95 | Focal motor seizures (HP:0011153) | 2.28669597 |
| 96 | Mutism (HP:0002300) | 2.28557516 |
| 97 | Failure to thrive in infancy (HP:0001531) | 2.27982044 |
| 98 | Cerebral inclusion bodies (HP:0100314) | 2.27370316 |
| 99 | Postaxial hand polydactyly (HP:0001162) | 2.24997519 |
| 100 | Absent phalangeal crease (HP:0006109) | 2.23629633 |
| 101 | Calf muscle hypertrophy (HP:0008981) | 2.22444508 |
| 102 | Central scotoma (HP:0000603) | 2.19924043 |
| 103 | Hemiparesis (HP:0001269) | 2.19160082 |
| 104 | Neuronal loss in central nervous system (HP:0002529) | 2.19109751 |
| 105 | Round ear (HP:0100830) | 2.18252496 |
| 106 | Myoglobinuria (HP:0002913) | 2.14679910 |
| 107 | Pancreatic fibrosis (HP:0100732) | 2.11192581 |
| 108 | Depression (HP:0000716) | 2.09796572 |
| 109 | Renal hypoplasia (HP:0000089) | 2.07662725 |
| 110 | Myoclonus (HP:0001336) | 2.07113186 |
| 111 | Abnormality of the calf musculature (HP:0001430) | 2.06793293 |
| 112 | Spastic gait (HP:0002064) | 2.06422585 |
| 113 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.05273202 |
| 114 | Delusions (HP:0000746) | 2.04700568 |
| 115 | Chronic bronchitis (HP:0004469) | 2.04426400 |
| 116 | Cerebral hypomyelination (HP:0006808) | 2.02128750 |
| 117 | Neonatal onset (HP:0003623) | 2.01870709 |
| 118 | Myopathic facies (HP:0002058) | 2.01699308 |
| 119 | Sensory axonal neuropathy (HP:0003390) | 2.01371327 |
| 120 | Papilledema (HP:0001085) | 2.01172406 |
| 121 | Epileptiform EEG discharges (HP:0011182) | 1.99970980 |
| 122 | Hyperglycinemia (HP:0002154) | 1.98260947 |
| 123 | Exercise-induced muscle cramps (HP:0003710) | 1.96681360 |
| 124 | Lower limb muscle weakness (HP:0007340) | 1.95407741 |
| 125 | Prolonged QT interval (HP:0001657) | 1.95333726 |
| 126 | Dysmetria (HP:0001310) | 1.95084910 |
| 127 | EMG: neuropathic changes (HP:0003445) | 1.94040979 |
| 128 | Tetraplegia (HP:0002445) | 1.93139773 |
| 129 | Impaired social interactions (HP:0000735) | 1.93057303 |
| 130 | Abnormal social behavior (HP:0012433) | 1.93057303 |
| 131 | Left ventricular hypertrophy (HP:0001712) | 1.90502641 |
| 132 | Conjunctival hamartoma (HP:0100780) | 1.90134999 |
| 133 | Rhabdomyolysis (HP:0003201) | 1.89617672 |
| 134 | Ulnar claw (HP:0001178) | 1.88630324 |
| 135 | True hermaphroditism (HP:0010459) | 1.88560720 |
| 136 | Epileptic encephalopathy (HP:0200134) | 1.88307960 |
| 137 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.87609770 |
| 138 | Ulnar deviation of the wrist (HP:0003049) | 1.86965144 |
| 139 | Amblyopia (HP:0000646) | 1.84384224 |
| 140 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.84049100 |
| 141 | Metabolic alkalosis (HP:0200114) | 1.83669684 |
| 142 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.83073865 |
| 143 | Frequent falls (HP:0002359) | 1.81832360 |
| 144 | Ventricular fibrillation (HP:0001663) | 1.79919033 |
| 145 | Mitochondrial inheritance (HP:0001427) | 1.79101470 |
| 146 | Asymmetric septal hypertrophy (HP:0001670) | 1.77601451 |
| 147 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.76984891 |
| 148 | EEG with generalized epileptiform discharges (HP:0011198) | 1.74006771 |
| 149 | Choreoathetosis (HP:0001266) | 1.73872019 |
| 150 | Abnormality of sodium homeostasis (HP:0010931) | 1.73614676 |
| 151 | Supranuclear gaze palsy (HP:0000605) | 1.73569120 |
| 152 | Incomplete penetrance (HP:0003829) | 1.73346068 |
| 153 | Anxiety (HP:0000739) | 1.73064658 |
| 154 | Rimmed vacuoles (HP:0003805) | 1.73020123 |
| 155 | Urinary urgency (HP:0000012) | 1.72864652 |
| 156 | Increased variability in muscle fiber diameter (HP:0003557) | 1.72105755 |
| 157 | Abnormal finger flexion creases (HP:0006143) | 1.71802420 |
| 158 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.71437705 |
| 159 | Hypokalemic alkalosis (HP:0001949) | 1.71382513 |
| 160 | Xerostomia (HP:0000217) | 1.70593560 |
| 161 | Subaortic stenosis (HP:0001682) | 1.70333536 |
| 162 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.69244072 |
| 163 | EMG: myopathic abnormalities (HP:0003458) | 1.66918635 |
| 164 | Specific learning disability (HP:0001328) | 1.66608803 |
| 165 | Agitation (HP:0000713) | 1.65318130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PHKG1 | 4.53746347 |
| 2 | PHKG2 | 4.53746347 |
| 3 | ARAF | 3.97957466 |
| 4 | EPHA4 | 3.65193764 |
| 5 | MAPKAPK5 | 3.60731644 |
| 6 | GRK5 | 3.24453116 |
| 7 | DAPK2 | 2.92082590 |
| 8 | LATS2 | 2.36383257 |
| 9 | CAMKK2 | 2.34909102 |
| 10 | BUB1 | 2.26662853 |
| 11 | FRK | 2.06265286 |
| 12 | MAP3K2 | 1.99763946 |
| 13 | MAP3K9 | 1.99229781 |
| 14 | KSR2 | 1.95654858 |
| 15 | CASK | 1.95222508 |
| 16 | PAK3 | 1.89784381 |
| 17 | MINK1 | 1.75318425 |
| 18 | OBSCN | 1.73855583 |
| 19 | CAMK2D | 1.71214414 |
| 20 | LIMK1 | 1.66448850 |
| 21 | TRIB3 | 1.65798771 |
| 22 | MAP2K7 | 1.62410272 |
| 23 | RIPK4 | 1.60681523 |
| 24 | CAMK2B | 1.60210149 |
| 25 | STK24 | 1.60053259 |
| 26 | CAMK1G | 1.58621931 |
| 27 | ILK | 1.56569365 |
| 28 | CAMK2G | 1.56536970 |
| 29 | PIM2 | 1.50188900 |
| 30 | CAMK1D | 1.49959299 |
| 31 | MAP2K4 | 1.48557538 |
| 32 | NTRK2 | 1.41404163 |
| 33 | CDK15 | 1.39116944 |
| 34 | PLK2 | 1.37746304 |
| 35 | MAPK15 | 1.35830566 |
| 36 | NTRK1 | 1.34348889 |
| 37 | CDK18 | 1.33648305 |
| 38 | ERBB3 | 1.33597648 |
| 39 | UHMK1 | 1.30749854 |
| 40 | MARK3 | 1.30029827 |
| 41 | SGK494 | 1.29470182 |
| 42 | SGK223 | 1.29470182 |
| 43 | BRAF | 1.28537682 |
| 44 | RPS6KA2 | 1.27519450 |
| 45 | CDK11A | 1.27033310 |
| 46 | PRPF4B | 1.27018066 |
| 47 | MAP3K4 | 1.24597470 |
| 48 | NME1 | 1.22338520 |
| 49 | PRKCG | 1.21785080 |
| 50 | MAP3K12 | 1.19564993 |
| 51 | FER | 1.08970261 |
| 52 | MAPKAPK3 | 1.07345918 |
| 53 | CAMK1 | 1.05683645 |
| 54 | DAPK1 | 1.02549159 |
| 55 | STK39 | 0.99747197 |
| 56 | CDK19 | 0.98155521 |
| 57 | TESK1 | 0.97136559 |
| 58 | PNCK | 0.96770648 |
| 59 | RET | 0.94844557 |
| 60 | LMTK2 | 0.94435901 |
| 61 | SGK2 | 0.92790099 |
| 62 | DYRK1A | 0.91458046 |
| 63 | MAPK13 | 0.90419048 |
| 64 | BCKDK | 0.89872707 |
| 65 | FGFR2 | 0.87310837 |
| 66 | CAMKK1 | 0.87263992 |
| 67 | CSNK1A1L | 0.85278700 |
| 68 | NUAK1 | 0.83358028 |
| 69 | AKT3 | 0.80190494 |
| 70 | SGK1 | 0.79551938 |
| 71 | PRKD3 | 0.79353025 |
| 72 | NTRK3 | 0.79004826 |
| 73 | CSNK1G2 | 0.76827538 |
| 74 | MARK1 | 0.75813249 |
| 75 | TTN | 0.75375572 |
| 76 | CAMK2A | 0.75290761 |
| 77 | MAP3K13 | 0.74602474 |
| 78 | CSNK1G3 | 0.73893797 |
| 79 | CDK5 | 0.73461297 |
| 80 | PTK2B | 0.72492881 |
| 81 | NEK1 | 0.72148875 |
| 82 | SIK3 | 0.71728467 |
| 83 | MARK2 | 0.70005829 |
| 84 | SGK3 | 0.68481754 |
| 85 | PAK6 | 0.67094893 |
| 86 | MAP3K1 | 0.63686121 |
| 87 | SCYL2 | 0.62574108 |
| 88 | PINK1 | 0.61781947 |
| 89 | MAP2K2 | 0.60076391 |
| 90 | CDK14 | 0.57970728 |
| 91 | PRKCZ | 0.57120960 |
| 92 | MAP2K1 | 0.56571769 |
| 93 | WNK3 | 0.55272709 |
| 94 | ICK | 0.53606733 |
| 95 | PRKCE | 0.53087452 |
| 96 | TESK2 | 0.50894216 |
| 97 | HIPK2 | 0.50000476 |
| 98 | RPS6KA3 | 0.49767248 |
| 99 | PKN1 | 0.48959952 |
| 100 | STK38 | 0.48094716 |
| 101 | IRAK1 | 0.45756087 |
| 102 | CAMK4 | 0.45685211 |
| 103 | MAPK10 | 0.45457985 |
| 104 | DAPK3 | 0.44931976 |
| 105 | SIK2 | 0.44186258 |
| 106 | STK11 | 0.43724489 |
| 107 | WNK4 | 0.43104759 |
| 108 | TYRO3 | 0.43048335 |
| 109 | STK16 | 0.40612334 |
| 110 | PRKG1 | 0.39377395 |
| 111 | CSNK1G1 | 0.38890260 |
| 112 | PRKCH | 0.38687098 |
| 113 | PDPK1 | 0.38312429 |
| 114 | MAPK12 | 0.37453323 |
| 115 | FGFR3 | 0.36950223 |
| 116 | MAP2K6 | 0.36575637 |
| 117 | CCNB1 | 0.36525270 |
| 118 | PRKACB | 0.36415388 |
| 119 | PDK1 | 0.35813102 |
| 120 | WNK1 | 0.35519006 |
| 121 | NEK9 | 0.35047013 |
| 122 | PRKAA1 | 0.35031449 |
| 123 | MAP3K5 | 0.34501325 |
| 124 | PRKACA | 0.34005018 |
| 125 | MAP3K11 | 0.32572531 |
| 126 | ROCK2 | 0.29921741 |
| 127 | CSNK1D | 0.29486273 |
| 128 | TRPM7 | 0.29140310 |
| 129 | RAF1 | 0.28151003 |
| 130 | TNK2 | 0.27449500 |
| 131 | FYN | 0.27341597 |
| 132 | CSNK1A1 | 0.26935505 |
| 133 | MOS | 0.26512615 |
| 134 | STK38L | 0.26510143 |
| 135 | PIK3CG | 0.26072556 |
| 136 | OXSR1 | 0.26041296 |
| 137 | MAP3K7 | 0.24655562 |
| 138 | ROCK1 | 0.24510261 |
| 139 | NEK6 | 0.24150442 |
| 140 | BMPR2 | 0.23104221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 9.31682783 |
| 2 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 3.45726985 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.31076147 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.01625166 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 1.99343161 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 1.95788031 |
| 7 | Taste transduction_Homo sapiens_hsa04742 | 1.91143483 |
| 8 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.86036937 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.84804720 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 1.72601138 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 1.70542691 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.67580085 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.62220811 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.61904589 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.58059381 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.55578719 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.55504397 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.54418352 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.50324154 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.43998204 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.40821302 |
| 22 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.39764293 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.38778657 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.38672925 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.35217138 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29866532 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24160090 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22565813 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.20252479 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17866802 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.16932705 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.12404417 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06742895 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04365872 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01119178 |
| 36 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.99657950 |
| 37 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.97118580 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 0.96814346 |
| 39 | Melanogenesis_Homo sapiens_hsa04916 | 0.94311389 |
| 40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.93025683 |
| 41 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.91090856 |
| 42 | Circadian rhythm_Homo sapiens_hsa04710 | 0.89953541 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88931658 |
| 44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88601870 |
| 45 | Huntingtons disease_Homo sapiens_hsa05016 | 0.88025847 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 0.84081365 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.82003836 |
| 48 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81496217 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81404220 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 0.81199198 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80516833 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80505803 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79785276 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79537265 |
| 55 | Glioma_Homo sapiens_hsa05214 | 0.77748925 |
| 56 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77670061 |
| 57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76569842 |
| 58 | Alcoholism_Homo sapiens_hsa05034 | 0.76208781 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75954023 |
| 60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75684376 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75134038 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.73413449 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67881079 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65645946 |
| 65 | Nicotine addiction_Homo sapiens_hsa05033 | 0.65451606 |
| 66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65406295 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.65249923 |
| 68 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63513031 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62654933 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62640206 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62378858 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59490848 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59291871 |
| 74 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58643977 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58561002 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57826795 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56025549 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54326447 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53179698 |
| 80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51153304 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49426999 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49036756 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46009157 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45548326 |
| 85 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43227084 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41492555 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41046358 |
| 88 | Melanoma_Homo sapiens_hsa05218 | 0.40532509 |
| 89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.37344992 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36791234 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.36244956 |
| 92 | Phagosome_Homo sapiens_hsa04145 | 0.35727528 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.35342560 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34922021 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34586144 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31885770 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31508763 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31251129 |
| 99 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.30550306 |
| 100 | Axon guidance_Homo sapiens_hsa04360 | 0.29813239 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29697286 |
| 102 | Tight junction_Homo sapiens_hsa04530 | 0.29464346 |
| 103 | Long-term depression_Homo sapiens_hsa04730 | 0.29201364 |
| 104 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.28747621 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.28477296 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27546340 |
| 107 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.27318545 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27262662 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26485448 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.25282115 |
| 111 | Cocaine addiction_Homo sapiens_hsa05030 | 0.25136557 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24827873 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24699553 |
| 114 | Carbon metabolism_Homo sapiens_hsa01200 | 0.23852340 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22010047 |
| 116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21498575 |
| 117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20812335 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.20334571 |
| 119 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.20220069 |
| 120 | Histidine metabolism_Homo sapiens_hsa00340 | 0.19953157 |
| 121 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.19210125 |
| 122 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.19054210 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.18972662 |
| 124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.17564432 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17564192 |

